SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 406 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,018,313 | -11.2% | 16,650 | -16.1% | 2.60% | -4.8% |
| Q2 2023 | $2,271,619 | -54.5% | 19,836 | -45.2% | 2.74% | -60.4% |
| Q1 2023 | $4,988,068 | -39.6% | 36,190 | -43.2% | 6.91% | -12.9% |
| Q4 2022 | $8,261,502 | +24.1% | 63,756 | +5.9% | 7.93% | +23.9% |
| Q3 2022 | $6,658,000 | +76.8% | 60,231 | +19.9% | 6.40% | +56.2% |
| Q2 2022 | $3,765,000 | -18.7% | 50,225 | -15.3% | 4.10% | +27.3% |
| Q1 2022 | $4,632,000 | -46.8% | 59,299 | -38.7% | 3.22% | -23.0% |
| Q4 2021 | $8,707,000 | +8.0% | 96,695 | +10.9% | 4.18% | +16.8% |
| Q3 2021 | $8,065,000 | +32.5% | 87,213 | +11.3% | 3.58% | +27.5% |
| Q2 2021 | $6,089,000 | +18.5% | 78,330 | +13.6% | 2.81% | -7.6% |
| Q1 2021 | $5,138,000 | +1.6% | 68,937 | +132.3% | 3.04% | -21.2% |
| Q4 2020 | $5,059,000 | – | 29,672 | – | 3.86% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 290,000 | $44,066,000 | 9.14% |
| Avoro Capital Advisors LLC | 1,400,000 | $212,730,000 | 7.35% |
| NEXTHERA CAPITAL LP | 50,317 | $7,646,000 | 6.37% |
| Eventide Asset Management | 1,123,000 | $170,640,000 | 5.19% |
| RTW INVESTMENTS, LP | 604,236 | $91,814,000 | 4.90% |
| Casdin Capital, LLC | 335,000 | $50,903,250,000 | 4.76% |
| Copernicus Capital Management, LLC | 30,000 | $4,559,000 | 4.06% |
| CADIAN CAPITAL MANAGEMENT, LP | 548,500 | $83,345,000 | 3.76% |
| Dynamic Capital Management Ltd | 4,677 | $711,000 | 3.54% |
| Camber Capital Management LP | 500,000 | $75,975,000 | 3.54% |